IntegraGen SA (ALINT.PA) • EURONEXT
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold ALINT.PA in your mock portfolio yet.
The negative EPS and resulting negative P/E ratio indicate that IntegraGen SA is currently unprofitable. Without evidence of improving earnings or a clear path to profitability, the financial profile remains weak. The market is likely pricing in significant business or balance-sheet risk despite the low absolute share price.
The stock’s 30.4% rise over the last month shows short-term positive momentum, and the current price is modestly above the 200-day moving average, which is a mild technical positive. However, given the very low absolute price level and loss-making status, the move appears more like a speculative bounce than a confirmed uptrend.
Alternative data show limited growth or even mild deterioration in external engagement. Web traffic is very low, social media followings are small or slightly declining, and there are no job openings, which collectively suggest muted business expansion and weak brand or customer traction.
Overall, IntegraGen SA’s recent price bounce and slight move above its 200-day moving average are outweighed by ongoing losses and weak alternative data signals. The combination of negative earnings, minimal digital traction, and no visible hiring momentum points to a fragile equity story where recent gains could prove unstable.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started